Skip to main content
. 2021 Sep 23;14:123. doi: 10.1186/s13048-021-00874-1

Fig. 2.

Fig. 2

Serum Galectin -1 levels in a) healthy controls vs patients with Ovarian Tumours. b) Premenopausal patients vs postmenopausal patients